Recipharm to acquire Hospira subsidiary
This article was originally published in Scrip
Recipharm is to acquire a subsidiary of Hospira, Wasserburger Arzneimittelwerk, for an undisclosed sum.
The contract manufacturing organisation, which is based in Wasserburg, Germany, is focused on aseptic filling and lyophilsation of pharmaceuticals into ampoules and vials on behalf of customers.
The acquisition is part of Recipharm's goal of becoming a leading contract development and manufacturing organisation by offering a 'one-stop shop' for the development and manufacture of large and small-molecule biopharmaceuticals, the company said.
The Swedish firm plans to continue Wasserburger's current operations and retain all of its employees.
Recipharm moved to acquire the UK contract manufacturer of biological Cobra Biomanufacturing last month, valuing the company at £1 million (scripnews.com, December 18th, 2009).